Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Pembrolizumab-induced dual endocrine disruption: A case report
María Carmen Dameto Pons; Elena González Arnáiz; María Antequera González; Xavier F. Pérez Candel; Diana Ariadel Cobo; Javier Castañón Alonso; María D. Ballesteros Pomar;
Endocrinol Diabetes Nutr. 2025;72:
Posthemithyroidectomy hypothyroidism. Prevalence and predictive markers. Comparison between patients with euthyroid and hyperthyroid nodular goitre
Luis García Pascual; Carlos Puig-Jové; Andreu Simó-Servat; Lluís García-González;
Endocrinol Diabetes Nutr. 2024;71:298-307
Prevalence of cancer in patients with hypothyroidism: Analysis using big data tools
Juan J. Díez; Luis Cabrera; Pedro Iglesias; María Benavent; Guillermo Argüello; Guillermo López; Alejandro Parralejo; Javier Leal;
Endocrinol Diabetes Nutr. 2023;70 Supl 3:50-8